Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer

Clinical trial NCT05420519 · UNKNOWN

Trial details

NCT number: NCT05420519
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Tumor Renal Cell Carcinoma Advanced Cancer

Start date: 2021-12-31
Primary completion: 2023-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.